Skip to Main content Skip to Navigation
Journal articles

The emerging role of the IL-17B/IL-17RB pathway in cancer

Abstract : Among inflammatory mediators, a growing body of evidence emphasizes the contribution of the interleukin 17 (IL-17) cytokine family in malignant diseases. Besides IL-17A, the prototypic member of the IL-17 family, several experimental findings strongly support the role of the IL-17B/IL-17 receptor B (IL-17RB) pathway in tumorigenesis and resistance to anticancer therapies. In mouse models, IL-17B signaling through IL-17RB directly promotes cancer cell survival, proliferation, and migration, and induces resistance to conventional chemotherapeutic agents. Importantly, recent work by our and other laboratories showed that IL-17B signaling dramatically alters the tumor microenvironment by promoting chemokine and cytokine secretion which foster tumor progression. Moreover, the finding that elevated IL-17B is associated with poor prognosis in patients with pancreatic, gastric, lung and breast cancer strengthens the results obtained in pre-clinical studies and highlights its clinical relevance. Here, we review the current understanding on the IL-17B/IL-17RB expression patterns and biological activities in cancer and highlight issues that remain to be addressed to better characterize IL-17B and its receptor as potential targets for enhancing the effectiveness of the existing cancer therapies.
Complete list of metadatas

Cited literature [63 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02546091
Contributor : Nathalie Bonnefoy <>
Submitted on : Friday, April 17, 2020 - 4:50:36 PM
Last modification on : Tuesday, April 21, 2020 - 2:03:19 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2020-09-01

Please log in to resquest access to the document

Identifiers

Collections

Citation

Jeremy Bastid, Cecile Dejou, Aurelie Docquier, Nathalie Bonnefoy. The emerging role of the IL-17B/IL-17RB pathway in cancer. Frontiers in Immunology, Frontiers, In press, Epub ahead of print. ⟨10.3389/fimmu.2020.00718⟩. ⟨inserm-02546091⟩

Share

Metrics

Record views

29